| Authors: |
Korte EWH; Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hiel MAJ; Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Bolling MC; Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Dunn P; International Pemphigus & Pemphigoid Foundation, Roseville, CA, USA., Murrell DF; Department of Dermatology, St George Hospital, University of New South Wales, Sydney, Australia., Werth VP; Division of Dermatology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Yale M; International Pemphigus & Pemphigoid Foundation, Roseville, CA, USA., Spuls PI; Department of Dermatology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Public Health, Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Meijer JM; Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Horváth B; Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, European Reference Network for Rare Skin Diseases (ERN SKIN), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. |
